Clinical Study
Microscopic Evaluation, Molecular Identification, Antifungal Susceptibility, and Clinical Outcomes in Fusarium, Aspergillus and, Dematiaceous Keratitis
Table 3
Clinical outcomes of Fusarium, Aspergillus, and Dematiaceous keratitis.
|
Groups |
Mean visual acuity before treatment (LOGMAR) |
Mean visual acuity after treatment (LOGMAR) | Change in visual acuity |
Worsened | Poor response (No PL to PL/PL to PR) | Slight response (improved Snelens/ CF to Snelens) | Good response (PL to CF/Snelens) |
| Fusarium | 1.82 (0.8–3) | 1.17 (0–3) | 3 (20%) | 8 (53.3%) | 3 (20%) | 1 (6.7%) | Aspergillus | 2.08 (0.48–3) | 1.68 (0–3) | 4 (16.7%) | 12 (49.9%) | 5 (20.9%) | 3 (12.5%) | Dematiaceous | 2.45 (0.48–3) | 0.91 (0–2) | 0 | 3 (30%) | 7 (70%)* | 0 |
|
|
P value <0.05 when compared to the other two groups.
|